Efficacy of chimeric molecules directed towards multiple somatostatin and dopamine receptors on inhibition of GH and prolactin secretion from GH-secreting pituitary adenomas classified as partially responsive to somatostatin analog therapy - Jaquet, P; Gunz, G; Saveanu, A; Dufour, H; Taylor, J; Dong, J; Kim, S; Moreau, J P; Enjalbert, A; Culler, M D (Eur J Endocrinol, 2005)